Polaryx Therapeutics, Inc. (PLYX): Total Assets
$5.17M
As of 2025-12-31
$11.81M
As of 2026-06-30
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.17M | +3.4% | 2026-03-24, Balance as of period end |
| 2024-12-31 | $5.00M | n/a | 2026-03-24, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | 2025-12-31 | $5.17M | +3.4% |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | $5.16M | -51.4% |
| Enveric Biosciences, Inc. (ENVB) | 2025-12-31 | $5.10M | +65.3% |
| Azitra, Inc. (AZTR) | 2025-12-31 | $5.03M | -31.7% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $5.33M | -60.5% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $5.37M | -6.8% |
| International Stem Cell Corp (ISCO) | 2025-12-31 | $4.82M | -6.8% |
| AEON Biopharma, Inc. (AEON) | 2025-12-31 | $5.56M | +77.0% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $5.56M | -10.3% |
Compare PLYX, PTPI, ENVB, AZTR side by side · Screen every company in Pharmaceutical Preparations ↗